Use of cotton rats for preclinical evaluation of measles vaccines

被引:30
作者
Wyde, PR
Stittelaar, KJ
Osterhaus, ADME
Guzman, E
Gilbert, BE
机构
[1] Baylor Coll Med, Dept Mol Virol & Microbiol, Houston, TX 77030 USA
[2] Erasmus Univ, Inst Virol, NL-3000 DR Rotterdam, Netherlands
[3] Inst Publ Hlth & Environm Protect, Lab Vaccine Res, NL-3720 BA Bilthoven, Netherlands
关键词
measles vaccines; measles; cotton rats; measles virus; animal models;
D O I
10.1016/S0264-410X(00)00151-1
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
The continued prevalence and medical impact of measles worldwide has created interest in the development of new generations of measles vaccines. Monkeys can be used for preclinical testing of these vaccines. However, a more practical and less expensive animal model is highly desirable, particularly for initial vaccine development and evaluation. Cotton rats have been shown to support the replication of different strains of measles virus (MV), and thus may be useful for these purposes, To test this concept, the immunogenicity and protective efficacy of two standard (Moraten and trivalent measles, mumps, rubella) and four experimental (two recombinant ALVAC, one ISCOM subunit and live attenuated Edmonston-Zagreb) MV vaccines were evaluated in naive cotton rats, and cotton rats with passively acquired MV-specific neutralizing serum antibodies. All of the test vaccines were immunogenic and protected naive animals from pulmonary infection and viral dissemination. However, under the conditions utilized, only the Edmonston-Zagreb vaccine provided such protection to animals with significant levels of passively acquired MV-specific neutralizing antibodies. The results of these tests and the potential of using cotton rats as an animal model for preliminary testing of MV vaccines are discussed. (C) 2000 Elsevier Science Ltd. All rights reserved.
引用
收藏
页码:42 / 53
页数:12
相关论文
共 53 条
[1]  
AABY P, 1988, LANCET, V2, P809
[2]   LONG-TERM SURVIVAL AFTER EDMONSTON-ZAGREB MEASLES VACCINATION IN GUINEA-BISSAU - INCREASED FEMALE MORTALITY-RATE [J].
AABY, P ;
KNUDSEN, K ;
WHITTLE, H ;
LISSE, IM ;
THAARUP, J ;
POULSEN, A ;
SODEMANN, M ;
JAKOBSEN, M ;
BRINK, L ;
GANSTED, U ;
PERMIN, A ;
JENSEN, TG ;
ANDERSEN, H ;
DASILVA, MC .
JOURNAL OF PEDIATRICS, 1993, 122 (06) :904-908
[3]   A canarypox vector expressing cytomegalovirus (CMV) glycoprotein B primes for antibody responses to a live attenuated CMV vaccine (Towne) [J].
Adler, SP ;
Plotkin, SA ;
Gonczol, E ;
Cadoz, M ;
Meric, C ;
Ben Wang, JA ;
Dellamonica, P ;
Best, AM ;
Zahradnik, J ;
Pincus, S ;
Berencsi, K ;
Cox, WI ;
Gyulai, Z .
JOURNAL OF INFECTIOUS DISEASES, 1999, 180 (03) :843-846
[4]   FATAL MEASLES INFECTION IN MARMOSETS PATHOGENESIS AND PROPHYLAXIS [J].
ALBRECHT, P ;
LORENZ, D ;
KLUTCH, MJ ;
VICKERS, JH ;
ENNIS, FA .
INFECTION AND IMMUNITY, 1980, 27 (03) :969-978
[5]   Induction of immune responses to HIV-1 by canarypox virus (ALVAC) HIV-1 and gp120 SF-2 recombinant vaccines in uninfected volunteers [J].
Belshe, RB ;
Gorse, GJ ;
Mulligan, MJ ;
Evans, TG ;
Keefer, MC ;
Excler, JL ;
Duliege, AM ;
Tartaglia, J ;
Cox, WI ;
McNamara, J ;
Hwang, KL ;
Bradney, A ;
Montefiori, D ;
Weinhold, KJ .
AIDS, 1998, 12 (18) :2407-2415
[6]   Edmonston-Zagreb measles vaccine: A good vaccine with an image problem [J].
Bennett, JV ;
Cutts, FT ;
Katz, SL .
PEDIATRICS, 1999, 104 (05) :1123-1124
[7]   Studies on measles. I. Susceptibility of monkeys to the virus of measles. [J].
Blake, FG ;
Trask, JD .
JOURNAL OF EXPERIMENTAL MEDICINE, 1921, 33 (03) :385-U19
[8]   IMMUNIZATION WITH CANARYPOX VIRUS EXPRESSING RABIES GLYCOPROTEIN [J].
CADOZ, M ;
STRADY, A ;
MEIGNIER, B ;
TAYLOR, J ;
TARTAGLIA, J ;
PAOLETTI, E ;
PLOTKIN, S .
LANCET, 1992, 339 (8807) :1429-1432
[9]  
CLASSEN I, 1999, RES IMMUNOL, P531
[10]   Studies on experimental adjuvanted influenza vaccines:: comparison of immune stimulating complexes (Iscoms™) and oil-in-water vaccines [J].
Coulter, A ;
Wong, TY ;
Drane, D ;
Bates, J ;
Macfarlan, R ;
Cox, J .
VACCINE, 1998, 16 (11-12) :1243-1253